Related Experiment Video
Updated: Sep 16, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Personalized risk score for post-COVID-19 condition: Bayesian directed acyclic graphic approach
Sam Li-Sheng Chen1, Chen-Yang Hsu2,3, Tin-Yu Lin4
1School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
A new composite risk score (CRS) helps predict Post-COVID-19 condition (PCC) risk using a Bayesian model. This tool aids personalized medical care and early diagnosis for individuals affected by COVID-19.
Area of Science:
- Epidemiology
- Computational Biology
- Public Health
Background:
- Post-COVID-19 condition (PCC) is a growing concern in the post-pandemic landscape.
- Accurate risk assessment is crucial for managing PCC and its impact on individuals and healthcare systems.
Purpose of the Study:
- To develop a personalized composite risk score (CRS) for Post-COVID-19 condition (PCC).
- To estimate PCC probability across different SARS-CoV-2 variants using a Bayesian directed acyclic graphic (DAG) model.
Main Methods:
- Utilized a Bayesian DAG model on meta-analysis data from 41 studies (over 860,000 COVID-19 cases).
- Incorporated 215 combinations of demographic and health-related risk factors.
- Developed a CRS ranging from 0 to 500, categorized into risk quartiles.
Main Results:
- The CRS accurately predicted PCC risk across various SARS-CoV-2 variants (Wild/D614G/Alpha, Delta, Omicron BA.1/BA.2).
- External validation confirmed predictive accuracy, with minor deviations in the BA.5 Omicron subset.
- The model demonstrated adaptability for emerging SARS-CoV-2 subvariants.
Conclusions:
- The Bayesian DAG model provides an adaptable framework for PCC risk prediction.
- The CRS facilitates individualized medical care and prioritization for early PCC diagnosis.
- This approach supports informed healthcare resource allocation for high-risk populations.
Related Concept Videos
Relative Risk
Hazard Ratio
For example, in a clinical trial...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cancer Survival Analysis
Causality in Epidemiology
Coronary Artery Disease IV: Preventive Measures

